Hemorrhagic fever with renal syndrome: Pathogenesis and clinical picture

Frontiers in Cellular and Infection Microbiology

Volumn 6, Issue FEB, 2016, Pages

  Jiang, Hong ^a   Du, Hong ^a   Wang, Li M ^b   Wang, Ping Z ^a   Bai, Xue F ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bunyavirus; Hantaan virus; Hantavirus; Hemorrhagic fever with renal syndrome; Pathogenesis

Indexed keywords

BETA INTERFERON; BETA3 INTEGRIN; CREATININE; CXCL1 CHEMOKINE; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOPROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON REGULATORY FACTOR; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; MYXOVIRUS RESISTANCE PROTEIN A; NUCLEOCAPSID PROTEIN; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PROTEIN ZO1; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; RIBAVIRIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ANTIVIRUS AGENT; VIRUS ANTIBODY;

ACUTE KIDNEY FAILURE; APODEMUS AGRARIUS; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD VESSEL PERMEABILITY; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CONTINUOUS RENAL REPLACEMENT THERAPY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HANTAVIRUS; HEMODIALYSIS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HOST; HUMAN; HYPOTENSION; INFECTION SENSITIVITY; INNATE IMMUNITY; NATURAL KILLER CELL; PATHOGENESIS; PLAQUE ASSAY; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; VIRUS LOAD; ASIA; CELLULAR IMMUNITY; ENDOTHELIUM CELL; EUROPE; HANTAAN VIRUS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; KIDNEY; PATHOLOGY; TRANSMISSION; VIROLOGY;

ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; ASIA; ENDOTHELIAL CELLS; EUROPE; HANTAAN VIRUS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; KIDNEY;

EID: 85006216338     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2016.00001     Document Type: Review

References (97)

1. Ahlm, C., Linderholm, M., Juto, P., Stegmyr, B., and Settergren, B. (1994). Prevalence of serum IgG antibodies to Puumala virus (hemorrhagic fever with renal syndrome) in norther Sweden. Epidemiol. Infect. 113, 129-136. doi: 10.1017/S0950268800051542
2. Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801. doi: 10.1016/j.cell.2006.02.015
3. Alexeyev, O. A., Ahlm, C., Billheden, J., Settergran, B., Wadell, G., and Juto, P. (1994). Elevated levels of total and Puumala virus-specific immunoglobulin E in the Scandinavian type of hemorrhagic fever with renal syndrome. Clin. Diagn. Lab. Immunol. 1, 269-272.
4. Araki, K., Yoshimatsu, K., Ogino, M., Ebihara, H., Lundkvist, Å., Kariwa, H., et al. (2001). Truncated hantavirus nucleocapsid proteins for serotyping Hantaan, Seoul, and Dobrava hantavirus infections. J. Clin. Microbiol. 39, 2397-2404. doi: 10.1128/JCM.39.7.2397-2404.2001
5. Belkaid, Y., and Rouse, B. T. (2005). Natural regulatory T cells in infectious disease. Nat. Immunol. 6, 353-360. doi: 10.1038/ni1181
6. Beutler, B. A. (2009). TLRs and innate immunity. Blood 113, 1399-1407. doi: 10.1182/blood-2008-07-019307
7. Björkström, N. K., Lindgren, T., Stoltz, M., Fauriat, C., Braun, M., Evander, M., et al. (2011). Rapid expansion and long term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 208, 13-21. doi: 10.1084/jem.20100762
8. Bossi, F., Fischetti, F., Pellis, V., Bulla, R., Ferrero, E., and Mollnes, T. E. (2004). Platelet-activationg factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex. J. Immunol. 173, 6921-6927. doi: 10.4049/jimmunol.173.11.6921
9. Byzova, T. V., Goldman, C. K., Pampori, N., Thomas, K. A., Bett, A., Shattil, S. J., et al. (2000). A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol. Cell. 6, 851-860. doi: 10.1016/s1097-2765(00)00083-6
10. Chapman, L. E., Mertz, G. J., Peters, C. J., Jolson, H. M., Khan, A. S., Ksiazek, T. G., et al. (1999). Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Antivir. Ther. (Lond). 4, 211-219.
11. Denecke, B., Bigalke, B., Haap, M., Overkamp, D., Lehnert, H., and Haas, C. S. (2010). Hantavirus infection: a neglected diagnosis in thrombocytopenia and fever? Mayo Clin. Proc. 85, 1016-1020. doi: 10.4065/mcp.2009.0040
12. Deter, J., Chaval, Y., Galan, M., Gauffre, B., Morand, S., Henttonen, H., et al. (2008). Kinship, dispersal and hantavirus transmission in bank and common voles. Arch. Virol. 153, 435-444. doi: 10.1007/s00705-007-0005-6
13. Du, H., Li, J., Jiang, W., Yu, H., Zhang, Y., Wang, J., et al. (2014a). Clinical study of critical patients with hemorrhagic fever with renal syndrome complicated by acute respiratory distress syndrome. PLoS ONE 9:e89740. doi: 10.1371/journal.pone.0089740
14. Du, H., Li, J., Yu, H. T., Jiang, W., Zhang, Y., Wang, J. N., et al. (2014b). Early indicators of severity and construction of a risk model for prognosis based upon laboratory parameters in patients with hemorrhagic fever with renal syndrome. Clin. Chem. Lab. Med. 52, 1667-1675. doi: 10.1515/cclm-2014-0016
15. Dvorak, H. F. (2006). Discovery of vascular permeability factor (VPF). Exp. Cell Res. 312, 522-526. doi: 10.1016/j.yexcr.2005.11.026
16. Easterbrook, J. D., Zink, M. C., and Klein, S. L. (2007). Regulatory T cells enhance persistence of the zoonotic pathogen Seoul virus in its reservoir host. Proc. Natl. Acad. Sci. U.S.A. 104, 15502-15507. doi: 10.1073/pnas.0707453104
17. Frese, M., Kochs, G., Feldmann, H., Hertkorn, C., and Haller, O. (1996). Inhibition of Bunyaviruses, Phleboviruses, and Hantaviruses by Human MxA Protein. J. Virol. 70, 915-923.
18. Gavrilovskaya, I. N., Gorbunova, E. E., and Mackow, E. R. (2010). Pathogenic Hantaviruses direct the adherence of quiescent platelets to infected endothelial cell. J. Virol. 84, 4832-4839. doi: 10.1128/JVI.02405-09
19. Gavrilovskaya, I. N., Gorbunova, E. E., Mackow, N. A., and Mackow, E. R. (2008). Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J. Virol. 82, 5797-5806. doi: 10.1128/JVI.02397-07
20. Gavrilovskaya, I. N., Peresleni, T., Geimonen, E., and Mackow, E. R. (2002). Pathogenic hantaviruses selectively inhibit beta 3 integrin directed endothelial cell migration. Arch. Virol. 147, 1913-1931. doi: 10.1007/s00705-002-0852-0
21. Gavrilovskaya, I. N., Shepley, M., Shaw, R., Ginsberg, M. H., and Mackon, E. R. (1998). Beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. U.S.A. 95, 7074-7079. doi: 10.1073/pnas.95.12.7074
22. Gorbunova, E., Gavrilovskaya, I. N., and Mackow, E. R. (2010). Pathogenic Hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. J. Virol. 84, 7405-7411. doi: 10.1128/JVI.00576-10
23. Gorbunova, E. E., Gavrilovskaya, I. N., Pepini, T., and Mackow, E. R. (2011). VEGFR2 and Src kinase inhibitors suppress Andes Virus-induced endothelial cell permeability. J. Virol. 85, 2296-2303. doi: 10.1128/JVI.02319-10
24. Gowen, B. B., Wong, M. H., Jung, K. H., Sanders, A. B., Mendenhall, M., Bailey, K. W., et al. (2007). In vitro and in vivo activities of T-705 against arenavirus and Bunyavirus infectious. Antimicrob. Agents Chemother. 51, 3168-3176. doi: 10.1128/AAC.00356-07
25. Grvrilovskaya, I. N., Gorbunova, E. E., Mackow, N. A., and Mackow, E. R. (2008). Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit Hantavirus-directed permeability. J. Virol. 82, 5797-5806. doi: 10.1128/JVI.02397-07
26. Guhl, S., Franke, R., Schielke, A., Johne, R., Krüger, D. H., Babina, M., et al. (2010). Infection of in vivo differentiated human mast cells with hantaviruses. J. Gen. Virol. 91, 1256-1261. doi: 10.1099/vir.0.019505-0
27. Hall, P. R., Leitão, A., Ye, C., Kilpatrick, K., Hjelle, B., Oprea, T. I., et al. (2010). Small molecule inhibitors of hantavirus infection. Bioorg. Med. Chem. Lett. 20, 7085-7091. doi: 10.1016/j.bmcl.2010.09.092
28. Handke, W., Oelschlegel, R., Franke, R., Krüger, D. H., and Rang, A. (2009). Hantaan virus triggers TLR3-dependent innate immune responses. J. Immunol. 182, 2849-2858. doi: 10.4049/jimmunol.0802893
29. Hannah, M. F., Bajic, V. B., and Klein, S. L. (2008). Sex differences in the recognition of and innate antiviral responses to Seoul virus in Norway rats. Brain Behav. Immun. 22, 503-516. doi: 10.1016/j.bbi.2007.10.005
30. Hayasaka, D., Maeda, K., Ennis, F. A., and Terajima, M. (2007). Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes. Virus Res. 123, 120-127. doi: 10.1016/j.virusres.2006.08.006
31. Hjertqvist, M., Klein, S. L., Ahlm, C., and Klingström, J. (2010). Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerg infec Dis. 16, 1584-1586. doi: 10.3201/eid1610.100242
32. Huggins, J. W., Hsiang, C. M., Cosgriff, T. M., Guang, M. Y., Smith, J. I., Wu, Z. O., et al. (1991). Prospective, double-bind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J. Infect. Dis. 164, 1119-1127. doi: 10.1093/infdis/164.6.1119
33. Jiang, H., Wang, P. Z., Zhang, Y., Xu, Z., Sun, L., Wang, L. M., et al. (2008). Hantaan virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon, interleukin-6 and tumor necrosis factor-alpha. Virology 380, 52-59. doi: 10.1016/j.virol.2008.07.002
34. Jiang, W., Wang, P. Z., Yu, H. T., Zhang, Y., Zhao, K., Du, H., et al. (2014). Development of a SYBR Green I based one-step real-time PCR assay for the detection of Hantaan virus. J. Virol. Methods. 196, 145-151. doi: 10.1016/j.jviromet.2013.11.004
35. Jonsson, C. B., Figueiredo, L. T., and Vapalahti, O. (2010). A global perspective on hantavirus ecology, epidemiology, and disease. Clin. Microbiol. Rev. 23, 412-441. doi: 10.1128/CMR.00062-09
36. Kaiwa, H., Yoshimatsu, K., and Arikawa, J. (2007). Hantavirus infection in East Asia. Comp. Immunol. Microbiol. Infect. Dis. 30, 341-356. doi: 10.1016/j.cimid.2007.05.011
37. Kanerva, M., Melén, K., Vaheri, A., and Ulkunen, I. (1996). Inhibition of Puumala and Tula Hantaviruses in Vero Cells by MxA Protein. Virology 224, 55-62. doi: 10.1006/viro.1996.0506
38. Keynan, Y., Card, C. M., McLaren, P. J., Dawood, M. R., Kasper, K., and Fowke, K. R. (2008). The role of regulatory T cells in chronic and acute viral infections. Clin. Infect. Dis. 46, 1046-1052. doi: 10.1086/529379
39. Khaiboullina, S. F., Netski, D. M., Krumpe, P., and St. Jeor, S. C. (2000). Effects of tumor necrosis factor alpha on sin nombre virus infection in vitro. J. Virol. 74, 11966-11971. doi: 10.1128/JVI.74.24.11966-11971.2000
40. Khaiboullina, S. F., Morzunov, S. P., and St. Jeor, S. C. (2005a). Hantavirus: molecular biology, evolution and pathogenesis. Curr. Mol. Med. 5, 773-790. doi: 10.2174/156652405774962317
41. Khaiboullina, S. F., Rizvanov, A. A., Deyde, V. M., and St. Jeor, S. C. (2005b). Andes virus stimulates interferon-inducible MxA protein expression in endothelial cells. J. Med. Virol. 75, 267-275. doi: 10.1002/jmv.20266
42. Khaiboullina, S. F., Martynova, E. V., Khamidullina, Z. L., Lapteva, E. V., Nikolaeva, I. V., Anokhin, V. V., et al. (2014). Upregulation of IFN-γ and IL-12 is associated with a milder form of hantavirus hemorrhagic fever with renal syndrome. Eur. J. Clin. Microbiol. Infect. Dis. 33, 2149-2156. doi: 10.1007/s10096-014-2176-x
43. Kim, S., Sung, S. H., An, H. R., Jun, Y. H., Yu, M., Ryu, D. R., et al. (2010). A case report of crescentic glomerulonephritis associated with hantaan virus infection. Nephrol. Dial. Transplant. 25, 2790-2792. doi: 10.1093/ndt/gfq253
44. Klein, S. L., Marks, M. A., Li, W., Glass, G. E., Fang, L. Q., Ma, J. Q., et al. (2011). Sex differences in the incidence and case fataltity rates from hemorrhagic fever with renal syndrome in China, 2004-2008. Clin. Infec. Dis. 52, 1414-1421. doi: 10.1093/cid/cir232
45. Krautkrämer, E., Grouls, S., Stein, N., Reiser, J., and Zeier, M. (2011). Pathogenic old world hantaviruses infect renal glomerular and tubular cells and induce disassembling of cell-to-cell contacts. J. Virol. 85, 9811-9823. doi: 10.1128/JVI.00568-11
46. Koivula, T. T., Tuulasvaara, A., Hetemäki, L., Mäkelä, S. M., Mustonen, J., Sironen, T. Y., et al. (2014). Regulatory T cell response correlates with the severity of human hantavirus infection. J. Infec. 68, 387-394. doi: 10.1016/j.jinf.2013.11.007
47. Li, M., Ji, Y., Dong, Y., Zhou, Y., Ren, H., Xie, M., et al. (2013). The detection of vascular endothelial growth factor in serum of patients with hemorrhagic fever with renal syndrome. Inflamatory 36, 962-967. doi: 10.1007/s10753-013-9627-x
48. Liu, Y. X., Feng, D., Zhang, Q., Jia, N., Zhao, Z. T., De Vlas, S. J., et al. (2007). Key differentiating features between scrub typhus and hemorrhagic fever with renal syndrome in northern China. Am. J. Trop. Med. Hyg. 76, 801-805. Available online at: http://www.ajtmh.org/content/76/5/801.full.pdf+html
49. Li, G., Pan, L., Mou, D., Chen, Y., Zhang, Y., Li, X., et al. (2006). Characterization of Truncated Hantavirus Nucleocapsid proteins and their application for serotyping. J. Med. Virol. 78, 926-932. doi: 10.1002/jmv.20643
50. Li, Z., Bai, X., and Bian, H. (2002). Serologic diagnosis of Hantaan Virus infection based on a peptide antigen. Clin. Chem. 48, 645-647. Available online at: http://www.clinchem.org/content/48/4/645.full.pdf+html
51. Linderholm, M., Ahlm, C., Settergren, B., Waage, A., and Tärnvik, A. (1996). Elevated plasma levels of tumor necrosis factor (TNF)-a, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 173, 38-43. doi: 10.1093/infdis/173.1.38
52. Lindgern, T., Ahlm, C., Mohamed, N., Evander, M., Ljunggren, H. G., and Björkström, N. K. (2011). Longitudinal analysis of the human T cell response during acute hantavirus infection. J. Virol. 85, 10252-10260. doi: 10.1128/JVI.05548-11
53. Lohoff, M., and Mark, T. W. (2005). Roles of interferon-regulatory factors in T-helper-cell differentiation. Nat. Rev. Immunol. 5, 125-135. doi: 10.1038/nri1552
54. Lundkvist, Å., Björsten, S., and Niklasson, B. (1993). Immunoglobulin G subclass against the structural components of Puumala virus. J. Clin. Microbiol. 31, 368-372.
55. Maes, P., Clement, J., Groeneveld, P. H., Colson, P., Huizinga, T. W., and Van Ranst, M. (2006). Tumor necrosis factor-a genetic predisposing factors can influence clinical severity in nephropathia epidemica. Viral Immunol. 19, 558-564. doi: 10.1089/vim.2006.19.558
56. Moreli, M. L., Marques-Silva, A. C., Pimentel, V. A., and da Costa, V. G. (2014). Effectiveness of the ribavirin in treatment of hantavirus infections in the Americas and Eurasia: a meta-analysis. Virusdisease 25, 385-389. doi: 10.1007/s13337-014-0219-7
57. Mou, D. L., Wang, Y. P., Huang, C. X., Li, G. Y., Pan, L., Yang, W. S., et al. (2006). Cellular entry of Hantaan virus A9 strain: specific interactions with β3 integrins and a novel 70 kDa protein. Biochem. Biophy. Res. Commun. 339, 611-617. doi: 10.1016/j.bbrc.2005.11.049
58. Mustonen, J., Mäkelä, S., Outinen, T., Laine, O., Jylhävä, J., Arstila, P. T., et al. (2013). The pathogenesis of nephropathia epidemica: new knowledge and unanswered questions. Antiviral Res. 100, 589-604. doi: 10.1016/j.antiviral.2013.10.001
59. Murzabaeva, R. T. (2002). Interferon in patients with hemorrhagic fever with renal syndrome. Zh. Mikrobiol. Epidemiol. Immunobiol. 5, 74-76.
60. Mustonen, J., Partanen, K., Kanerva, M., Ptetilä, K., Vapalahti, O., Pasternack, A., et al. (1996). Genetic susptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 49, 217-221. doi: 10.1038/ki.1996.29
61. Nicacio, C. C., Björling, E., and Lundkvist, Å. (2000). Immunoglobulin A response to Puumala Hantavirus. J. Gen. Virol. 81, 1453-1461. doi: 10.1099/0022-1317-81-6-1453
62. Oelschlegel, R., Krüger, D. H., and Rang, A. (2007). MxA-independent inhibition of Hantaan virus replication induced by type I and type II interferon in vitro. Vir Res. 127, 100-105. doi: 10.1016/j.virusres.2007.03.027
63. Outinen, T. K., Mäkelä, S. M., Ala-Houhala, I. O., Huhtala, H. A. S., Hurme, M., Paakkala, A. S., et al. (2010). The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations. BMC Infect. Dis. 10:132. doi: 10.1186/1471-2334-10-132
64. Outinen, T. K., Mäkelä, S., Huhtala, H., Hurme, M., Meri, S., Pörsti, I., et al. (2012). High pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced nephropathia epidemica. Eur. J. Clin. Microbiol. Infect. Dis. 31, 957-963. doi: 10.1007/s10096-011-1392-x
65. Peters, C. J., and Khan, A. S. (2002). Hantavirus pulmonary syndrome: the new American hemorrhagic fever. Clin. Infect. Dis. 34, 1224-1231. doi: 10.1086/339864
66. Pensiero, M. N., Sharefkin, J. B., Dieffenbach, C. W., and Hay, J. (1992). Hantaan virus infection of human endothelial cells. J. Virol. 66, 5929-5936.
67. Rang, A. (2010). Modulation of innate immune response by Hantaviruses. Crit. Rev. Immunol. 30, 515-527. doi: 10.1615/CritRevImmunol.v30.i6.20
68. Rouse, B. T., and Sehrawat, S. (2010). Immunity and immunopathology to viruses: what decides the outcome? Nat. Rev. Immunol. 10, 514-526. doi: 10.1038/nri2802
69. Rusnak, J. M., Byrne, W. R., Chung, K. N., Gibbs, P. H., Kim, T. T., Boudreau, E. F., et al. (2009). Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral Res. 81, 68-76. doi: 10.1016/j.antiviral.2008.09.007
70. Saksida, A., Duh, D., Korva, M., and Avsic-Zupanc, T. (2008). Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J. Infect. Dis. 197, 681-685. doi: 10.1086/527485
71. Saksida, A., Wraber, B., and Avšic-Županc, T. (2011). Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndrome. BMC Infect. Dis. 11:142. doi: 10.1186/1471-2334-11-142
72. Sane, J., Laine, O., Mäkelä, S., Paakkala, A., Jarva, H., Mustonen, J., et al. (2012). Complement activation in Puumala hantavirus infection correlates with disease severity. Ann. Med. 44, 468-475. doi: 10.3109/07853890.2011.573500
73. Safronetz, D., Falzarano, D., Scott, D. P., Furuta, Y., Feldmann, H., and Gowen, B. B. (2013). Antiviral efficacy of Favipiravir against two prominent etiological agents of Hantaviruses pulmonary syndrome. Antimicrob. Agents Chemother. 57, 4673-4680. doi: 10.1128/AAC.00886-13
74. Schmaljohn, C., and Hjelle, B. (1997). Hantaviruses: a global disease problem. Emerg. Infect. Dis. 3, 95-103. doi: 10.3201/eid0302.970202
75. Schountz, T., Prescott, J., Cogswell, A. C., Oko, L., Mirowsky-Garcia, K., Galvez, A. P., et al. (2007). Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus. Proc. Natl. Acad. Sci. U.S.A. 104, 15496-15501. doi: 10.1073/pnas.0707454104
76. Shrivastava-Ranjan, P., Rollin, P. E., and Spiropoulou, C. F. (2010). Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J. Virol. 84, 11227-11234. doi: 10.1128/JVI.01405-10
77. Taruishi, M., Yoshimatsu, K., Araki, K., Okumura, M., Nakamura, I., Kajino, K., et al. (2007). Analysis of the immune response of Hantaan virus nucleocapsid protein-specific CD8+ T cells in mice. Virology 365, 292-301. doi: 10.1016/j.virol.2007.02.039
78. Terajima, M., and Ennis, F. A. (2011). T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever renal syndrome. Viruses 3, 1059-1073. doi: 10.3390/v3071059
79. Vaheri, A., Strandin, T., Hepojoki, J., Sironen, T., Henttonen, H., Mäkelä, S., et al. (2013). Uncovering the mysteries of hantavirus infections. Nature Reviews. 11, 539-550. doi: 10.1038/nrmicro3066
80. Vaheri, A., Strandin, T., Jääskeläinen, A. J., Vapalahti, O., Jarva, H., Lokki, M. L., et al. (2014). Pathophysiology of a serve case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant. Antiviral Res. 111, 23-25. doi: 10.1016/j.antiviral.2014.08.007
81. Wang, M. L., Lai, J. H., Zhu, Y., Zhang, H. B., Li, C., Wang, J. P., et al. (2009a). Genetic susceptibility to haemorrhagic fever with renal syndrome caused by Hantaan virus in Chinese Han population. Int. J. Immun. 36, 227-229. doi: 10.1111/j.1744-313X.2009.00848.x
82. Wang, M., Wang, J., Wang, T., Li, J., Hui, L., and Ha, X. (2013). Thrombcytopenia as a predictor of severe acute kidney injury in patients with Hantaan virus infections. PLoS ONE 8:e53236. doi: 10.1371/journal.pone.0053236
83. Wang, M., Zhu, Y., Wang, J., Lv, T., and Jin, B. (2011). Identification of three novel CTL Epitopes within nucleocapsid protein of hantaan virus. Virl. Immunol. 24, 449-454. doi: 10.1089/vim.2011.0026
84. Wang, P. Z., Huang, C. X., Zhang, Y., Li, Z. D., Yu, H. T., Zhang, Y., et al. (2009b). Analysis of the immune response to Hantaan virus nucleocapsid protein C-terminal-specific CD8+ T cells in patients with Hemorrhagic fever with renal syndrome. Viral Immunol. 22, 253-260. doi: 10.1089/vim.2008.0097
85. Wang, P. Z., Li, Z. D., Yu, H. T., Zhang, Y., Wang, W., Jiang, W., et al. (2012a). Elevated serum concentrations of inflammatory cytokines and chemokines in patients with haemorrhagic fever with renal syndrome. J. Int. Med. Res. 40, 648-656. doi: 10.1177/147323001204000227
86. Wang, W., Zhang, Y., Li, Y., Pan, L., Bai, L., Zhuang, Y., et al. (2012b). Dysregulation of the β3 integrin-VEGFR2 complex in Hantaan virus-directed hyperpermeability upon treatment with VEGF. Arch. Virol. 157, 1051-1061. doi: 10.1007/s00705-012-1245-7
87. Xiao, R., Yang, S., Koster, F., Ye, C., Stidley, C., and Hjelle, B. (2006). Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J. Infect. Dis. 194, 1403-1409. doi: 10.1086/508494
88. Xie, M., Dong, Y., Zhou, Y., Ren, H., Ji, Y., and Lv, S. (2013). Levels of HTNV-specific CD8+T lymphocytes in PBMC from the patients with hemorrhagic fever with renal syndrome. Intern. Emerg. Med. 8, 503-508. doi: 10.1007/s11739-011-0633-4
89. Xu, R., Yang, X. Y., Yang, D. F., Zou, C. Y., Gong, P. L., and Zeng, F. D. (2009). Phase I Evaluation of the safety and pharmacokinetics of a single-dose intravenous injection of a mruine monoclonal antibody against Hantaan Virus in healthy volunteers. Antimicrob. Agents Ch. 53, 5055-5059. doi: 10.1128/AAC.00728-09
90. Xu, Z., Wei, L., Wang, L., Wang, H., and Jiang, S. (2002). The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immunization. Biochem. Biophys. Res. Commun. 298, 552-558. doi: 10.1016/S0006-291X(02)02491-9
91. Yi, J., Xu, Z., Zhuang, R., Wang, J., Zhang, Y., Ma, Y., et al. (2013). Hantaan virus RNA load in patients having hemorrhagic fever with renal syndrome: correlation with disease severity. J. Infect. Dis. 207, 1457-1461. doi: 10.1093/infdis/jis475
92. Yu, H. T., Jiang, W., Du, H., Xing, Y., Bai, G. Z., Zhang, Y., et al. (2014). Involvement of the Akt/NF-κB pathways in the HTNV-Medicated increase of IL-6, CCL5, ICAM-1, and VCAM-1 in HUVECs. PLoS ONE 9:e93810. doi: 10.1371/journal.pone.0093810
93. Zhang, Y., Li, X. H., Jiang, H., Huang, C. X., Wang, P. Z., Mou, D. L., et al. (2008). Expression of L protein of Hantaan virus 84FLi strain and its application for recovery of minigenomes. APMIS 116, 1089-1096. doi: 10.1111/j.1600-0463.2008.01011.x
94. Zhang, Y. Z., Zou, Y., Fu, Z. F., and Plyusnin, A. (2010). Hantavirus infections in humans and animals, China. Emerging Infect. Dis. 16, 1195-1203. doi: 10.3201/eid1608.090470
95. Zhang, S., Wang, S., Yin, W., Liang, M., Li, J., Zhang, Q., et al. (2014a). Epidemic characteristics of hemorrhagic fever with renal syndrome in China, 2006-2012. BMC Infect. Dis. 14:384. doi: 10.1186/1471-2334-14-384
96. Zhang, Y., Liu, B., Ma, Y., Yi, J., Zhang, C., Zhang, Y., et al. (2014b). Hantaan virus infection induces CXCL10 expression through TLR3, RIG-I, and MDA-5 pathways correlated with the disease severity. Med. Inflamm. 2014:697837. doi: 10.1155/2014/697837
97. + cell populations in haemorrhagic fever with renal syndrome. Clin. Exp. Immunol. 156, 88-96. doi: 10.1111/j.1365-2249.2008.03858.x